Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,327,424 | $5,278,828 | $6,435,087 | $9,585,367 |
| - Cash | $3,621,806 | $3,891,422 | $3,828,863 | $5,682,425 |
| + Debt | $974,009 | $1,256,657 | $1,290,880 | $1,081,402 |
| Enterprise Value | $679,627 | $2,644,063 | $3,897,104 | $4,984,344 |
| Revenue | $1,901,109 | $1,860,539 | $2,181,189 | $3,038,391 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Gross Profit | $1,241,710 | $1,295,644 | $1,487,581 | $2,430,488 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| EBITDA | $105,069 | $334,310 | -$1,541,795 | $931,690 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |
| Net Income | -$216,662 | -$54,017 | -$1,914,918 | $416,509 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -578.4% | – |
| Operating Cash Flow | $243,887 | $199,487 | $46,493 | $665,293 |
| Capital Expenditures | -$186,375 | -$295,418 | -$402,459 | -$601,017 |
| Free Cash Flow | $57,512 | -$95,931 | -$355,966 | $64,276 |